Related Experiment Video
Updated: May 6, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Cause of death in mild cognitive impairment: a prospective study (NEDICES)
I Contador1, F Bermejo-Pareja, A J Mitchell
1Department of Basic Psychology, Psychobiology and Methodology of Behavioral Science, University of Salamanca, Salamanca, Spain; Department of Neurology, University Hospital '12 de Octubre', Madrid, Spain.
Background And Purpose:
Previous studies have reported the occurrence of increased mortality rates among individuals with mild cognitive impairment (MCI), but possible links between MCI subtypes and cause-specific mortality need to be explored. To examine short-term mortality (5 years), long-term mortality (13 years) and cause-specific mortality of individuals over 65 years of age suffering from MCI compared with cognitively unimpaired individuals in the Neurological Disorders in Central Spain (NEDICES) cohort.
Methods:
Mild cognitive impairment was classified using standardized psychometric and functional assessment in accordance with diagnostic convention. Cox's proportional hazards models, adjusted by sociodemographics and comorbidity factors, were used to assess the risk of death at 5 and 13 years of MCI subtypes compared with a reference group of older people without cognitive impairment (N = 2329). Causes of death were obtained from the National Population Register of Spain.
Results:
There were 1484 deceased individuals at 13 years. MCI subtypes were defined as amnestic single domain (N = 259), amnestic multiple domain (N = 197) and non-amnestic (N = 641). After adjusting for covariates, only the amnestic multiple domain MCI subtype showed an increased hazard ratio (HR) for mortality at 5 years versus the reference group. However, the HR for mortality at 13 years was increased for all MCI subtypes. The HR by MCI subtype was 1.19 in the non-amnestic subtype (95% CI 1.05-1.36), 1.31 in the amnestic single domain subtype (95% CI 1.10-1.56) and 1.67 in the amnestic multiple domain subtype (95% CI 1.38-2.02). In terms of cause-specific mortality, the chance of death from dementia was statistically higher in all MCI subtypes.
Conclusion:
Amnestic multiple domain MCI showed the greatest risk of mortality in comparison with other MCI subtypes at different intervals. Dementia was the only cause-specific mortality that was increased in MCI individuals.
Insights
Individuals with mild cognitive impairment (MCI) face increased mortality risks, particularly those with amnestic multiple domain MCI. Dementia is the primary cause-specific mortality linked to all MCI subtypes.
Area of Science:
- Neurology
- Gerontology
- Public Health
Background:
- Previous research indicates higher mortality rates in individuals with mild cognitive impairment (MCI).
- The specific links between different subtypes of MCI and cause-specific mortality require further investigation.
Purpose of the Study:
- To analyze short-term (5-year) and long-term (13-year) mortality.
- To examine cause-specific mortality in individuals over 65 with MCI compared to cognitively unimpaired individuals.
Main Methods:
- Mild cognitive impairment subtypes were classified using standardized assessments.
- Cox proportional hazards models analyzed mortality risk, adjusted for sociodemographics and comorbidities.
- Causes of death were sourced from the National Population Register of Spain.
Main Results:
- All MCI subtypes showed increased 13-year mortality risk.
- Amnestic multiple domain MCI exhibited the highest mortality hazard ratio at both 5 and 13 years.
- Dementia was the only cause-specific mortality significantly elevated across all MCI subtypes.
Conclusions:
- Amnestic multiple domain MCI presents the most significant mortality risk.
- Dementia is identified as the sole cause-specific mortality factor increased in individuals with MCI.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Related Concept Videos
Alzheimer Disease l: Introduction
Dementia l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Alzheimer Disease ll: Pathophysiology
Dementia
The progression of dementia is generally gradual....